Matinas Biopharma Holdings, Inc. (NYSE:MTNB)
Matinas Biopharma Holdings, Inc. (NYSE:MTNB) represented a move of -3.42 percent or $0.05 per share and closed its previous day trading session at $0.75. 741571 Shares were traded in the last trading session with an Average Volume of 2.95 Million Shares. The stock currently has a Market Capitalization of 86.02 Million.
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company’s proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company’s lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
The stock traded between $0.320 and $1.590 over 1-Year time period showing its price to sales ratio of 430.1. Matinas Biopharma Holdings, Inc. (NYSE:MTNB) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-8.54 and 200-Day Simple Moving Average of $16.64. Its Price to Free Cash Flow is 0 and Price to Book of 0.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Matinas Biopharma Holdings, Inc. (NYSE:MTNB) reported its Actual EPS of $-0.03/share. The analysts offering Earnings Estimates for the company were believing that Matinas Biopharma Holdings, Inc. could bring EPS of $-0.04/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 25 Percent.
Banco Bradesco Sa (NYSE:BBD)
In the last trading session, Banco Bradesco Sa (NYSE:BBD) added its value by 1.24% closing at the price of $9.8. The stock currently has market capitalization of 65.6 Billion, with average volume of 16.45 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Banco Bradesco Sa (NYSE:BBD) is showing beta of 0. This particular value of beta suggests that Banco Bradesco Sa (NYSE:BBD) has historically moved 0% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Banco Bradesco Sa (NYSE:BBD) is at $0.7.
The stock currently has RSI of 55.3. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Banco Bradesco’s main activities are the provision of banking and insurance services such as private and industrial credit loans, credit cards, mortgaged loans, 24 hour banking, health and life insurance, leasing, pension fund management and services for stock market investors.
Banco Bradesco Sa (NYSE:BBD) topped its 52-week high price of $13.18 on 01/31/18 and 52-Week Low Price of $ 6.49 on 09/13/18. The Stock currently has P/E (price to earnings ttm) of 14 and Weekly volatility of 3.48% and monthly volatility of 3.14% respectively.